Skip to content Skip to footer

INVESTOR RELATIONS

GENERAL ASSEMBLIES

2015:

Ordinary Meeting of Shareholders 10.06.2015

Announcement concerning the convening of the Ordinary General Meeting

Information on the overall number of shares in the company and the number of votes of these shares on the date of announcement.

Overall number of shares in Pharmena S.A. Company equals 8,795,052 shares, which entitle to 8,795,052 votes.

 

Draft resolutions

Form authorizing to exercise voting rights through a proxy:

Natural person, legal person

 

Form for granting the power of attorney to a natural person or a legal entity:

Natural person, legal person

 

2014:

Ordinary General Meeting 10 June 2014

 

Announcement concerning the convening of the Ordinary General Meeting

Information on the total number of shares of the company and the number of votes attached thereto on the announcement date.

The total number of shares of Pharmena S.A. is 8,795,052 shares which authorize their holders to cast 8,795,052 votes.

 

Draft resolutions

Form concerning the exercise of the right to vote by a proxy:

Natural person, legal person

Form concerning granting proxy by a natural or a legal person:

Natural person, legal person

 

2013:

Ordinary General Meeting 27 June 2013

 

Announcement concerning the convening of the Extraordinary General Meeting

Information on the total number of shares of the company and the number of votes attached thereto on the announcement date:

The total number of shares of Pharmena S.A. is 7,036,042 shares which authorize their holders to cast 7,036,042 votes.

* The total number of shares of Pharmena S.A. specified above does not include 781,782 Class C shares which were not registered yet by the registration court as at the date of the announcement concerning the convening of the Extraordinary General Meeting.

 

Draft resolutions

Form concerning the exercise of the right to vote by a proxy:

Natural person, legal person

Form concerning granting the power of proxy by a natural or a legal person:

Natural person, legal person

 

2012:

Extraordinary Shareholders Meeting as of 12 December 2012

 

Announcement of convening the Extraordinary Shareholders Meeting

Information on the total number of shares in the company and the number of votes of those shares on the announcement date:

Total number of shares in Pharmena S.A. amounts to 6,254,260 shares, which are entitled to 6,254,260 votes.

 

Draft resolutions

The form authorizing to exercise voting rights by proxy:

Natural person, Legal person

 

The form of granting the power of attorney by a natural person or legal entity:

Natural person, Legal person

 

The content of the adopted resolutions

Extraordinary Shareholders Meeting as of 21 August 2012

 

Announcement of convening the Extraordinary Shareholders Meeting

 

Information on the total number of shares in the company and the number of votes of those shares on the announcement date:

Total number of shares in Pharmena S.A. amounts to 6,254,260 shares, which are entitled to 6,254,260 votes.

 

Draft resolutions

The form authorizing to exercise voting rights by proxy:

Natural person, Legal person

 

The form of granting the power of attorney by a natural person or legal entity:

Natural person, Legal person

 

The content of the adopted resolutions

Ordinary Shareholders Meeting as of 14 May 2012.

 

Announcement of convening the Ordinary Shareholders Meeting

Information on the total number of shares in the company and the number of votes of those shares on the announcement date: Total number of shares in Pharmena S.A. amounts to 6,254,260 shares, which are entitled to 6,254,260 votes.

 

Draft resolutions

 

The form authorizing to exercise voting rights by proxy:

Natural person, Legal person

 

The form of granting the power of attorney by a natural person or legal entity:

Natural person, Legal person

The content of the adopted resolutions 

 

Dividend payment:

The Annual General Meeting as of 14 May made the following distribution of profit for 2011: the amount of PLN 312.713,00 was earmarked for dividend payment and the amount of PLN 296.284,21 was transferred to supplementary capital. The dividend was 5 groszy per share. The date of the shareholders rights to dividend (dividend date) was established for 14 June 2012, and the dividend payment date was established for 5 July 2012.

 

2011:

Ordinary General Meeting as of 6 June 2011.

Video report:  http://infoengine.pl/pharmena/

 

General Meeting Announcement

Information on the total number of shares in the company and the number of votes of those shares on the announcement date: Total number of shares in Pharmena S.A. amounts to 6,254,260 shares, which are entitled to 6,254,260 votes.

 

Draft resolutions

 The form authorizing to exercise voting rights by proxy:

Natural person, Legal person

 

The form of granting the power of attorney by a natural person or legal entity:

Natural person, Legal person

 

The content of the adopted resolutions by ZWZ 6 June 2011r.

 

2010:

Ordinary General Meeting as of 30 June 2010.

 

General Meeting Announcement

Information on the total number of shares in the company and the number of votes of those shares on the announcement date: Total number of shares in Pharmena S.A. amounts to 6,254,260 shares, which are entitled to 6,254,260 votes.

 

Draft resolutions 

The form authorizing to exercise voting rights by proxy:

Natural person, Legal person

 

The form of granting the power of attorney by a natural person or legal entity:

Natural person, Legal person

 

Documents to be submitted to the General Meeting:

Financial statement for 2009

 

The content of the adopted resolutions 

 

Dividend payment:

The Annual General Meeting as of 30 June made the following distribution of profit for 2009: the amount of PLN 375.255,60 was earmarked for dividend payment and the amount of PLN 396.286,30 was transferred to supplementary capital. The dividend was 6 groszy per share. The date of the shareholders rights to dividend (dividend date) was established for 4 August 2010, and the dividend payment date was established for 18 August 2010.

We care for your health by producing original and safe products with effectiveness confirmed by clinical trials.
contact

PHARMENA S.A.
ul. Gdańska 47/49
90-729 Łódź

Phone: +48 42 280 77 07 

Copyright PHARMENA SA 2024. All Rights Reserved.